title: Does Russia need a treat-to-target initiative?
authors.affiliation: Department of Vascular Pathology of Rheumatic Diseases and Early Arthritis Department, Research Institute of Rheumatology, Russian Academy of Medical Sciences (RAMS), Moscow, Russian Federation.
authors.forename: Eugeny L
authors.initials: EL
authors.lastname: Nasonov
authors.affiliation: Department of Vascular Pathology of Rheumatic Diseases and Early Arthritis Department, Research Institute of Rheumatology, Russian Academy of Medical Sciences (RAMS), Moscow, Russian Federation. karateev@irramn.ru dekar@inbox.ru.
authors.forename: Dmitry E
authors.initials: DE
authors.lastname: Karateev
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000453:epidemiology; D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000639:trends*; D010818:Practice Patterns, Physicians' / Q000639:trends; D015995:Prevalence; D016730:Program Development; D012426:Russia / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents; D001688:Biological Products